Celerion and Ricerca Biosciences Announce “The Biosimilars Alliance” to Offer Clients a More Effective Development Path for Biosimilars  
2/29/2012 6:08:26 AM

LINCOLN, Neb.--(BUSINESS WIRE)--Celerion, the premier provider of innovative early stage drug development solutions, and Ricerca Biosciences, a drug safety assessment expert in harnessing external preclinical innovation, announce the formation of “The Biosimilars Alliance.” The Biosimilars Alliance is focused on preclinical and early clinical assessment of biologics manufactured by a new supplier.